Thank you for inquiry about CMS145v12. To meet the numerator of this measure, a patient must be prescribed beta-blocker therapy at one or more visits during the measurement period in which they are eligible or have documentation in the current medication list that the patient is already taking beta-blocker therapy. A patient who is prescribed or actively taking beta-blocker therapy for a diagnosis prior to or in conjunction with an LVSD diagnosis is eligible for this measure.